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Abstract
Background: Folate (vitamin B9) is essential for cellular proliferation as it is involved in the biosynthesis of
deoxythymidine monophosphate (dTMP) and s-adenosylmethionine (AdoMet). The link between folate depletion
and the genesis and progression of cancers of epithelial origin is of high clinical relevance, but still unclear. We
recently demonstrated that sensitivity to low folate availability is affected by the rate of polyamine biosynthesis,
which is prominent in prostate cells. We, therefore, hypothesized that prostate cells might be highly susceptible to
genetic, epigenetic and phenotypic changes consequent to folate restriction.
Results: We studied the consequences of long-term, mild folate depletion in a model comprised of three syngenic
cell lines derived from the transgenic adenoma of the mouse prostate (TRAMP) model, recapitulating different
stages of prostate cancer; benign, transformed and metastatic. High-performance liquid chromatography analysis
demonstrated that mild folate depletion (100 nM) sufficed to induce imbalance in both the nucleotide and
AdoMet pools in all prostate cell lines. Random oligonucleotide-primed synthesis (ROPS) revealed a significant
increase in uracil misincorporation and DNA single strand breaks, while spectral karyotype analysis (SKY) identified
five novel chromosomal rearrangements in cells grown with mild folate depletion. Using global approaches, we
identified an increase in CpG island and histone methylation upon folate depletion despite unchanged levels of
total 5-methylcytosine, indicating a broad effect of folate depletion on epigenetic regulation. These genomic
changes coincided with phenotype changes in the prostate cells including increased anchorage-independent
growth and reduced sensitivity to folate depletion.
Conclusions: This study demonstrates that prostate cells are highly susceptible to genetic and epigenetic changes
consequent to mild folate depletion as compared to cells grown with supraphysiological amounts of folate (2 μM)
routinely used in tissue culture. In addition, we elucidate for the first time the contribution of these aspects to
consequent phenotype changes in epithelial cells. These results provide a strong rationale for studying the effects
of folate manipulation on the prostate in vivo, where cells might be more sensitive to changes in folate status
resulting from folate supplementation or antifolate therapeutic approaches.
Background
Folate (vitamin B9) is an essential nutrient required for
the de novo synthesis of deoxythymidine monopho-
sphate (dTMP) and s-adenosylmethionine (AdoMet)
through one-carbon metabolism and methionine cycle,
respectively (Figure 1). dTMP is then converted into the
triphosphate form (dTTP), which is required for the
synthesis of DNA, while AdoMet is pivotal in a number
of metabolic pathways, including the biosynthesis of
polyamines (reviewed in [1]), and intracellular methyla-
tion reactions that involve DNA, RNA and proteins,
including histones (reviewed in [2]).
Dietary manipulation of folate has been referred to as
a ‘double edge sword’ because pharmacological deple-
tion of folate by antifolate drugs prevents cancer cell
proliferation but might induce genetic and epigenetic
damage and consequent transformation in non-cancer-
ous cells. Conversely, folate supplementation might
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any medium, provided the original work is properly cited.prevent transformation but sustain the high proliferation
rates characteristic of cancer tissue [3]. Epidemiological
studies associating dietary intake of folate with the inci-
dence of different cancer types are often conflicting
likely reflecting this apparent paradox [3]. Molecular
studies, both in vitro and in vivo, suggest that indeed
the effects of folate depletion might depend on the cell
type [4] and on the cellular stage of transformation [5].
Strikingly, dietary folate depletion, alone or combined
with a low methyl diet, induced tumorigenesis of liver
and colon in rodents [6,7].
Based on seminal data from multiple laboratories it
was hypothesized that the mechanism of carcinogenesis
induced by folate depletion might include both genetic
damage consequent to altered availability of dTTP, and
epigenetic damage consequent to altered levels of Ado-
Met [8,9]. Decreased biosynthesis of dTMP, reflected by
an increase of dUTP (deoxyuridine triphosphate; Figure
1), leads to uracil misincorporation into the DNA,
which is expected to culminate in futile cycles of uracil
excision, single strand breaks and possibly chromosomal
breakage [8]. Epigenetic damage consequent to folate
depletion is a more controversial topic, as altered levels
of AdoMet and s-adenosylhomocysteine (AdoHcy; Fig-
ure 1) together with changes in the global levels of
DNA methylation are not consistently found in different
cell types [4,5]. Also, altered CpG island methylation
was found in the promoter of p53 and p16 of rodents
fed a folate/methyl deficient diet [6,10] raising the
p o s s i b i l i t yt h a tf o l a t ed e p l e t i o nm i g h th a v eag l o b a l
effect on CpG island methylation.
We recently demonstrated that one of the factors
affecting cellular sensitivity to folate depletion is the rate
of polyamine biosynthesis (spermine and spermidine),
which draws on AdoMet pools [11] (Figure 1). Polya-
mines are ubiquitous molecules essential for cellular life
whose intracellular concentration is tightly regulated
and maintained in the millimolar range in all cell types
[1]. Nonetheless, polyamine biosynthesis is characteristi-
cally high in certain tissues including prostate, which, in
addition to synthesizing polyamines for epithelial cell
replacement, secretes massive amounts of polyamines in
the prostatic fluid. Interestingly, a recent clinical trial
designed to study the effects of dietary folate supple-
mentation on the prevention of colorectal adenomas
r e p o r t e da st h em o s ts i g n i f i c a n tr e s u l taf i v et i m e
increase in prostate cancer incidence [12,13]. This find-
ing supports the idea that prostate cells, whose response
to folate depletion was never studied before, might be
highly dependent on folate in order to sustain their pro-
liferation and, therefore, might be exquisitely sensitive
to folate depletion. Thus, we hypothesized that prostate
cells might be exquisitely sensitive to genetic, epigenetic
and phenotypic changes consequent to folate depletion.
We present a study that, for the first time, simulta-
neously investigates several aspects characteristic of the
molecular, genetic, epigenetic and cellular response to
folate depletion in a model comprised of three syngenic
Figure 1 Folate, one-carbon metabolism, methionine cycle and polyamine biosynthesis overview. Dietary folate (left) is necessary for de
novo synthesis of deoxythymidine monophosphate (dTMP) and adenosylmethionine (AdoMet), which are necessary for DNA synthesis and
intracellular methylation reactions, respectively. AdoMet is also used for polyamine (spermidine and spermine) biosynthesis (top). dTMP can also
be scavenged by DNA degradation as thymidine, while AdoMet can be synthesized independently of folate by recycling methylthioadenosine
(MTA) into methionine through the methionine salvage pathway.
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of the mouse prostate (TRAMP) mouse model recapitu-
lating the different stages of prostate cancer - benign,
transformed and metastatic - in order to address the
possibility that different stages of transformation might
alter the response to folate depletion. Indeed, it was pre-
v i o u s l ys h o w nt h a tt h ee f f e c t s of mild folate depletion
on both the methionine pathway and the methylation
status differ among transformed and untransformed
human colon cell lines [5]. Our study, using three syn-
genic but phenotypically distinct cell lines, addresses
this possibility.
We report that prostate cells suffer genetic and epige-
netic instability along with changes in cell phenotype,
even in the presence of levels of folate (100 nM), that
allow for the undisturbed growth of other cell types
known to be sensitive to more severe folate depletion.
Specifically, we demonstrate for the first time that long-
term (20 population doublings; PD), mild folate deple-
tion alone is sufficient to induce chromosomal rearran-
gements and CpG island hypermethylation changes in
prostate cells. The analysis of cellular response to mild
folate depletion, integrating one-carbon metabolism,
methionine cycle and polyamine biosynthesis, with
genetic and epigenetic damage, and consequent pheno-
typical changes in three distinct prostate cell lines, helps
to clarify the interplay and contribution of each of these
pathways to carcinogenesis consequent to folate deple-
tion. These findings provide a strong rationale for study-
ing the effects of dietary manipulation of folate intake
on the prostate in vivo.
Results
Chronic mild folate depletion affects prostate cells’
phenotype
We grew three syngenic, but phenotypically distinct, clo-
nal cell lines; C-2D (benign), C-2G (tumourigenic) and
C-2H (metastatic), which were generated from a primary
prostate tumour in a TRAMP mouse [14], in folate-
restricted (100 nM) medium for 20 PD and refer to
these cells as D100, G100, and H100, respectively. In
parallel, we grew the cells for 20 PD with the supraphy-
siological levels of folic acid (2 μM) routinely used in
tissue culture and refer to these cells as DCtrl, GCtrl
and HCtrl. As expected, D100, G100 and H100 were
significantly depleted of folate (P < 0.01, data not
shown). The intracellular content of folate ranged
between 20 and 70 ng/5 million cells for DCtrl, GCtrl
and HCtrl but was <10 ng/5 million cells for D100,
G100 and H100. We have previously demonstrated that,
although colon cancer cell lines grow normally at 100
nM folic acid (FA), prostate cancer cell lines, due to
their high polyamine production, slow their growth to
varying degrees with this level of FA in the medium
[11]. In order to investigate for any permanent phenoty-
pical change that folate depletion might have induced in
the three cell lines we put them back into control med-
ium for 2 PD and tested them for their proliferation
rates, anchorage independent growth ability and sensi-
tivity to folate depletion.
G100, but not D100 and H100, slightly increased their
proliferation rate compared to their respective controls, as
they decreased their population doubling time from 15.8
h to 14 h (data not shown). All three cell lines grown for
20 PD in low folate medium significantly increased their
ability to form anchorage independent colonies in soft
agar over their respective controls (Figure 2A). DCtrl,
which is derived from the untransformed cell line C-2D,
could only form sporadic colonies in soft agar (Figure 2A,
top). Growth in low folate for 20 PD slightly, but signifi-
cantly (P < 0.05), increased the number of D100 cells cap-
able of anchorage independent growth in soft agar (Figure
2A, top). Folate depletion had a more dramatic effect on
2G and 2H cells, where the number of colonies per field
increased from two for GCtrl to 27 for G100 and from 14
for HCtrl to 33 for H100 (Figure 2A, bottom; P ≤ 0.001
each).
Interestingly, all cells grown with restricted amounts
of folate also significantly (P < 0.001 by two-way
ANOVA for all three cell lines) decreased their sensitiv-
i t yt of o l a t ed e p l e t i o na sw ee s t a b l i s h e db ya s s e s s i n g
folate-dependent growth curves on all six cell lines (Fig-
ure 2B). All three cell lines that had been grown for
20PD in low folate conditions demonstrated nearly
100% growth at 100 nM FA (Figure 2B, black bars),
while the DCtrl, GCtrl, and HCtrl versions of the cell
lines only grow to 80%, 19% and 60% (Figure 2B, white
bars). As expected, the total polyamine production was
not significantly affected by growth in low folate (Figure
2C), confirming that maintaining polyamine pools might
be a priority in prostate cells, thereby further increasing
the stress on AdoMet pools in a folate depleted state
(Figure 1). Nonetheless, we found that the spermidine to
spermine ratio (spd:spm ratio), which correlates with
cancer cells’ aggressiveness and proliferation rates in
s e v e r a lc e l lt y p e sin vivo [15] , was increased in G100
and H100 as compared to control cells (177% and 174%,
respectively; Figure 2C).
Chronic mild folate depletion induces DNA damage in
prostate cells in vitro
Analysis of nucleotide pools by high pressure liquid chro-
matography (HPLC) identified significantly increased
intracellular dUTP levels in D100, G100 and H100, up to
166%, 388% and 244% of DCtrl, GCtrl and HCtrl, respec-
tively (Figure 3A). Surprisingly, dTTP was not decreased
in any of the three cell lines upon mild folate depletion.
dTTP was, in fact, unchanged in both D100 and H100
and increased to 136% in G100 as compared to GCtrl
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increase, the dUTP:dTTP ratio was significantly
increased in all three cell lines to 155%, 285% and 229%
of their respective controls (Figure 3A). In order to deter-
mine if the increased dUTP:dTTP ratio led to increased
uracil misincorporation into the DNA we analysed the
cells’ DNA by random oligo-primed synthesis (ROPS)
[16,17] and detected significant uracil misincorporation
in all three cell lines (P < 0.01, P < 0.001, and P < 0.05 for
D100, G100, and H100, respectively; Figure 3B, left) and
increased amount of DNA single strand breaks in D100
and H100 (P <0 . 0 1a n dP < 0.001, respectively; Figure
3B, right).
In order to investigate if these static measures of
increased uracil misincorporation and single strand
DNA breaks were associated with accumulation of chro-
mosomal rearrangements we analysed G100 and GCtrl
cells by Spectral Karyotype Analysis (SKY) [18]. We
found that G100 and GCtrl shared five marker chromo-
somes in common, which were seen in greater than 15%
of metaphases studied (n =5 2f o rG C t r la n dn =7 6f o r
G100). As shown in Table 1, G100 cells exhibited five
additional marker chromosomes seen in 24% - 37% of
cells, which were never seen in any of 52 metaphase
cells in GCtrl. A representative metaphase cell from
each cell line is shown in Figure 3C demonstrating four
of the common marker chromosomes in GCtrl and four
of the new marker chromosomes in the G100 cell line
(Figure 3C, arrows). Looking at only the marker chro-
mosomes present in both cell lines (a-e, Table 1), we
observed eight different patterns of these marker chro-
mosomes in two or more cells in GCtrl and seven dif-
ferent patterns in G100, indicating significant cellular
heterogeneity is retained in the G100 cells. Figure 3D
shows the frequency distribution of the various patterns
(A-J) of these five marker chromosomes in both cell
lines. Two novel patterns, I and J, were seen in the
G100 cell line, while three relatively rare patterns (H, G,
and F) from the GCtrl line were not observed in G100.
These data do not support the hypothesis that clonal
selection occurred in the G100 cell line. Furthermore,
once the five novel marker chromosomes seen in G100
Figure 2 Chronic mild folate depletion affects prostate cells’ phenotype. (A) Anchorage-independent colonies in soft agar. 10,000 cells well
were seeded in semi-solid agar and allowed to grow for 4 weeks. Data presented is the average and SD of six replicates. (B) Folate dependent
growth rates. Growth rates (average and standard deviation) are calculated normalizing to growth in control amounts of folate (2 μM) set as
100%. (C) High-performance liquid chromatography analysis of polyamine pools. Results are the average and standard deviation of two
biologically independent samples. Values are normalized to those obtained in GCtrl cells, set as 100%. * = P < 0.05, ** = P < 0.01, *** = P <
0.001.
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nucleotide pools. Results are the average and standard deviation of three independent injections. Values are relative to cells grown in control
medium. (B) Single strand breaks generated by treatment with uracil-DNA-glycosidase (UDG) and Exonuclease III are quantified by random
oligonucleotide-primed synthesis performed with the Klenow polymerase in the presence of P
32-deoxcytidine triphosphate (dCTP; left). The
values of dCTP incorporation for all cell lines are the average of five replicates after subtraction of no enzyme treatment control background and
presented as an increase over cells grown in control medium. (C) Spectral karyotype analysis reveals that mild folate depletion induced de novo
chromosomal aberrations in G100. A representative metaphase from GCtrl (top), which exhibits only marker chromosomes common to both
GCtrl and G100 (Table 1) and a representative metaphase from G100 (bottom) which harbours the common t(1;10) translocation along with four
marker chromosomes, indicated by arrows, found frequently in G100, but never in GCtrl (Table 1). (D) Distribution of metaphase cells with
frequent patterns of marker chromosomes shared between GCtrl and G100 indicates lack of clonal selection in G100. Ten different patterns (A-J)
of the five marker chromosomes (a-e; Table 1) were found in two or more metaphase cells. G100 retains significant heterogeneity of patterns of
marker chromosomes including two novel patterns (I and J). Pattern A represents marker chromosomes a, b, c and d; pattern B = marker a;
pattern C = markers a and e; pattern D = marker b; pattern E = no marker chromosomes; pattern F = markers a, b and c; pattern G = markers b,
c and d; pattern H = markers b and c; pattern I = a, b, c, d and e; pattern J = marker e. * = P < 0.05, ** = P < 0.01, *** = P < 0.001.
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increased, rather than decreased heterogeneity in the
G100 cell line.
Chronic mild folate depletion affects AdoMet pools
We measured AdoMet and AdoHcy by HPLC in the
three cell lines grown with or without mild folate deple-
tion, as shown in Figure 4A. AdoMet levels in D100 were
reduced to 84% of those found in DCtrl cells. Conversely,
AdoMet was increased upon folate depletion in G100
and H100, where it was 131% and 132% of GCtrl and
HCtrl, respectively. As a consequence of folate depletion,
AdoHcy was increased in all cell lines as it reached 295%,
186% and 111% of levels detected in DCtrl, GCtrl, and
HCtrl, respectively (Figure 4A). The AdoMet:AdoHcy
ratio upon mild folate depletion was consequently
decreased in D100 and G100 (28% and 70%, of DCtrl and
GCtrl, respectively) and increased in H100 (118%; Figure
4A). Regardless of the changes observed in the AdoMet:
AdoHcy ratio, we found no significant change in the
total levels of 5-methylcytosine in the genome of D100,
G100 and H100 compared to their respective controls as
measured by liquid chromatography paired to mass spec-
trometry (LC-MS; Figure 4B) [19].
Increased CpG island methylation and histone
hypermethylation
Folate depletion has been associated with de novo CpG
methylation of candidate genes in colon and liver in
vivo [6,10,20]. In order to determine if mild folate deple-
tion induced global CpG island hypermethylation in the
prostate cell lines, we measured CpG island methylation
by restriction landmark genomic scanning (RLGS); a
global approach that allows for the simultaneous screen-
ing of the methylation status of over 1200 distinct CpG
islands in the genome. Each spot is named according to
a coordinate naming system as previously described [21]
and the sequence represented by approximately half of
the spots has been identified [22]. Comparing the three
cell lines grown in 100 nM FA to the same cells grown
in control medium we identified 14 hypermethylated
loci, as defined by RLGS spot loss [21,23]. As shown in
Table 2, three RLGS spot methylation events were
found in two of the three cell lines. For eight of the
RLGS loci, the sequences represented by the spot are
known (Table 2).
Similar to what was observed for changes in cell phe-
notype and uracil misincorporation, G100 had the most
dramatic change in methylation pattern with 13 hyper-
methylated loci, followed by H100 with three and D100
with one. Figure 4C shows representative regions of the
RLGS gels for each cell line demonstrating methylation
of two RLGS spots (4D20 and 4G11). Note that spot
4D20, corresponding to a CpG island 5’ to the Argef7
gene, shows greatly reduced intensity (increased methy-
lation) in both D100 and G100 cells compared to con-
trol (Figure 4C, left), while the spot 4G11,
corresponding to a CpG island 5’ to the Gm967 gene,
displayed decreased intensity in both G100 and H100
cells (Figure 4C, right).
In order to confirm that the decrease in spot intensity
identified by RLGS corresponded to an actual increase
of DNA methylation in the corresponding CpG islands,
we utilized the Sequenom platform for quantitative
bisulfite sequencing of the eight identified RLGS spots.
Mass array quantitative methylation analysis (MAQMA)
confirmed all the RLGS spot methylation events listed
i nT a b l e2 .F i g u r e4 Ds h o w st h eh y p e r m e t h y l a t i o no f
4D20 in D100 and G100, but not H100, compared to
the control cell lines.
In order to determine if mild folate depletion induced
any change in the global levels of histone methylation in
prostate cells like it was reported in other cell types
[24], we assessed global methylation levels at key resi-
dues of histone H3 (H3) in the G100 and GCtrl cell
lines. Using Western blot analysis of histones we mea-
sured H3 lysine 9 (K9) methylation, which is well char-
acterized and known to associate with a repressive
Table 1 Frequency of marker chromosomes detected by spectral karyotype analysis in >15% of metaphases analysed
in GCtrl or G100.
Cytogenetic event Frequency in Gctrl (n = 52 metaphase cells) Frequency in G100 (n = 76 metaphase cells)
a* t(11;12) 63% 55%
b t(1;10) 54% 58%
c t(10;18) 40% 34%
d t(6;19) 37% 33%
e Y 19% 51%
f rcpt(4;9) 0% 37%
g t(8;9) 0% 29%
h ins(X;8;X) 0% 26%
i t(X;11) 0% 26%
j t(3;6) 0% 24%
*Lowercase letters in bold indicate the name of the marker chromosome used to describe the patterns of marker chromosomes in Figure 3
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We found that mono-, di- and tri-methylation were all
increased at H3K9 in G100 cells (Figure 4E). In order to
understand if the increase in histone methylation was
specific to transcriptionally repressive histone modifica-
tions we analysed the levels of histone H3 lysine 36 di-
methylation (H3K36me2), as this modification is known
to associate with the body of transcriptionally active
genes. We found that H3K36me2 was also increased in
cells grown with mild folate depletion. This demon-
strates that the increase in histone methylation induced
by mild folate depletion is not specific to repressive
modifications and is probably not directly related to the
relatively low level of increased CpG island
hypermethylation.
Discussion
In this study we hypothesized that prostate cells might
be exquisitely sensitive to genetic, epigenetic and pheno-
typic changes consequent to folate depletion and investi-
gated the potential role that different stages of
transformation might play in affecting the response to
folate depletion. This topic is clinically relevant as anti-
folate drugs are currently used in the clinic for the
Figure 4 Mild folate depletion induces epigenetic damage in prostate cells. (A) High-performance liquid chromatography analysis of
adenosylmethionine/adenosylhomocysteine pools. Results are the average and standard deviation of three independent injections and are
presented relative to cells grown in control medium (100%). * = P < 0.05, ** = P < 0.01, *** = P < 0.001. (B) Analysis of total levels of 5-
methylcytosine by liquid chromatography-mass spectrometry. Results are the average and standard deviation of two independent injections.
Values are relative to cells grown in control medium. (C) Sections of restriction landmark genomic scanning (RLGS) gels including the spot 4D20,
which shows decreased intensity in both D100 and G100, and the spot 4G11, which shows decreased intensity in both G100 and H100. (D) Mass
array quantitative methylation analysis confirmed the methylation status of CpG identified by RLGS and associated to known loci. Peripheral
blood lymphocyte DNA was used as a 0% methylation control and an in vitro methylated aliquot of the same DNA as a 100% methylated
control. These DNAs were mixed at appropriate ratios to generate 75%, 50% and 25% methylated controls. The figure shows 4D20 as an
example. (E) Western Blot analysis of histone acid lysates run on sodium dodecyl sulphate-page gel revealed an increase of global H3K9
methylation (17 Kda) and H3K36 di-methylation (17 Kda) upon mild folate depletion.
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from opportunistic agents [25]. We found that even a
mild folate depletion (100 nM) was sufficient to induce
dramatic genetic and epigenetic damage along with
changes in prostate cell behaviour compared with cells
grown with the supraphysiological levels of folate routi-
nely used in tissue culture (2 μM). One hundred nano-
molar of folate is about five times the amount that
negatively impacts cell types such as colon, already
known to be sensitive to folate depletion [5,11,26,27].
The prostate cells’ exquisite sensitivity to folate deple-
tion is consistent with their characteristically high polya-
mine biosynthesis, which results in extra demand on the
methionine cycle and one-carbon metabolism in order
to sustain AdoMet pools [11].
The levels of polyamine biosynthesis might be one of
the factors behind the different response to folate deple-
tion in cells at different stages of transformation. Polya-
mine levels are significantly increased during the
process of transformation in order to sustain cell hyper-
proliferation [1,28]. Throughout our study, the untrans-
formed cell line C-2D suffered less dramatic changes
both at the molecular and phenotypical levels, consistent
with C-2D having the lowest polyamine levels among
the three cell lines [11].
Another mechanism that might differentiate the cells’
response to folate depletion could be their ability to effi-
ciently repair DNA. Cells at more advanced stages of
transformation are more likely to have impaired DNA
repair machinery and might accumulate mutations at a
higher rate. Consistent with this hypothesis, although
for all three cell lines the levels of uracil misincorpora-
tion followed closely the increase in the dUTP:dTTP
ratio (Figure 3A and 3B) - which in turn was more dra-
matic in cells with higher polyamine biosynthesis - the
levels of DNA damage measured as DNA single strand
breaks did not (Figure 3B and 3C). This suggests that
even if the dUTP:dTTP ratio and the levels of uracil
misincorporation were strictly dependent on the inher-
ent folate sensitivity of the cell lines and, therefore, poly-
amine biosynthesis, the ultimate amount of DNA
damage might also depend on the cells’ ability to repair
the DNA efficiently. Therefore, it is not surprising that
we found the highest amount of DNA single strand
breaks in the metastatic cell line C-2H (Figure 3C).
In addition we found that folate depletion by itself,
even at 100 nM folic acid, can induce major heritable
chromosomal rearrangements in prostate cells. Whilst it
has long been known that low folate levels can induce
fragile sites in both human and mouse chromosomes
[29-31], whether or not expression of the fragile sites is
associated with chromosomal rearrangements is unclear.
Spectral Karyotype Analysis (SKY) of the C-2G cells
grown with or without mild folate deficiency, identified
several novel chromosomal rearrangements upon mild
folate depletion (Table 1 and Figure 3), which are prob-
ably linked to the altered nucleotide pools, uracil misin-
corporation and single strand DNA breaks we observed
in the same cells. We found that a number of the break-
points for chromosomal translocations mapped in the
vicinity of known fragile sites, including a break at 6qC1
(marker chromosome i; Table 1) corresponding to
Fra6C1 in mouse and the human FRA4F [32].
Importantly, these novel chromosomal rearrangements
were never seen in the parental cell line and, in fact,
resulted in increased chromosomal heterogeneity (Figure
3D), therefore discounting the possibility of clonal selec-
tion of pre-existing changes. This is also important
when considering the decreased sensitivity to folate
depletion that the cells acquired after growth with limit-
ing amounts of folate (Figure 2B). We suggest that cells
might have adapted to growth in low folate through up
regulation of certain key pathways in order to sustain
their proliferation. In support of this hypothesis, when
we analysed molecule pools by HPLC, we observed that
despite imbalance in both the dUTP:dTTP ratio and
AdoMet:AdoHcy ratio, the overall levels of key mole-
cules, namely dTTP and AdoMet were maintained (Fig-
ures 3A and 4A).
An intriguing possibility is that upregulation of the
thymidine salvage pathway and the methionine salvage
pathway might occur in these cells upon mild folate
depletion (Figure 1). The thymidine salvage pathway
scavenges thymidine from degraded nucleic acids and
would, therefore, help in sustaining dTTP levels inde-
pendent of uracil conversion (Figure 1). Such a scenario
would be expected to result in an accumulation of
Table 2 Restriction landmark genomic scanning (RLGS)
methylation events detected in the three cell lines after
growth in 100 nM folic acid for 20 population doublings.
Spot name D100 G100 H100 Gene name
1E09 –– MET Igf2bp3
2B45 – MET MET Prodh
2C01 – MET – Mapk4
2D25 – MET – Cnnm1
2D47 – MET – AK147279
3C21 – MET – Nrxn2
4D20 MET* MET – Argef7
4G11 – MET MET Gm967
1E08 – MET – NA
2D15 – MET – NA
2F43 – MET – NA
2G58 – MET – NA
5G29 – MET – NA
6G44 – MET – NA
*MET indicates methylation of the NotI site represented by the RLGS spot.
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t h es a m et i m er e s u l ti nt h es u s t a i n m e n to fd T T Pp o o l s
due to salvage. Similarly, de novo synthesis of AdoMet is
mainly accomplished by the recycling of AdoHyc to
homocysteine, followed by N
5-methyl tetrahydrofolate
dependent synthesis of methionine, and is, therefore,
dependent on one-carbon metabolism. However, the
methionine salvage pathway, which recycles
methylthioadenosine out of polyamine biosynthesis into
methionine (Figure 1) could contribute to AdoMet bio-
synthesis independently of folate and result in sustained
AdoMet levels without utilization of AdoHcy, which
would accumulate as a byproduct of DNA, RNA and
protein methyltransferase reactions. This pathway has
been described mainly in liver, but its rate limiting
enzyme (methylthioadenosine phosphorylase) is ubiqui-
tous, was originally purified from rat prostate [33,34]
and is highly expressed in all three cell lines (data not
shown) used in this study.
Another novel contribution of this work is the demon-
stration that mild folate depletion induced global CpG
island hypermethylation in all three prostate cell lines.
Some of the methylation events were common among
cell lines, suggesting that CpG island hypermethylation
under conditions of folate depletion might not be occur-
ring randomly. Interestingly, in all the CpG island hyper-
methylation cases we observed, some methylation was
also present in the control cell lines which suggests that
mild folate depletion did not induce completely de novo
methylation at these promoters but, rather, increased
hypermethylation at already susceptible loci. Conversely,
despite the decreased AdoMet:AdoHcy ratio in D100 and
G100 cells, we could not detect global DNA hypomethy-
lation as assessed by LC-MS (Figure 4B). This result was
somewhat surprising but does not preclude the possibility
that mild folate depletion induced hypomethylation at
satellite repeats, as was previously reported in colon cell
lines in vitro [5]. Consistent with previous findings in the
rat liver [24,35], we also found that, in prostate cells,
mild folate depletion induced global histone hypermethy-
lation regardless of whether the specific marks were asso-
ciated with increased or decreased transcription (Figure
4E). All these events, genetic and epigenetic, probably
collaborate, resulting in the altered phenotype of the cells
that we observed (Figure 2).
Conclusions
Prostate cancer is the second leading cancer causing
mortality in men in the USA [36]. Our data show that
prostate cells are exquisitely sensitive to folate depletion,
with major genetic and epigenetic consequences result-
ing in altered cellular phenotypes. Insufficient dietary
folate intake or antifolate therapies, which are used for
the treatment of certain type of cancers as well as
infections by opportunistic agents [25], might increase
the incidence of prostate cancer due to the potentially
negative effects on the genome. Folate supplementation
on the other hand, although beneficial to untransformed
cells, might, in fact, accelerate the growth of existing,
dormant prostate cancer cells. This hypothesis is sup-
ported by the results of a recent clinical trial designed
to study the effects of folate supplementation on colon
polyp prevention, which resulted in a significant and
unexpected increase in the incidence of prostate cancer
[12,13]. Conversely, the heightened sensitivity of pros-
tate cancer cells to folate deficiency suggests that thera-
peutic use of antifolates might be particularly effective
in prostate cancer patients.
Methods
Cell culture
The three syngenic, but phenotypically distinct, clonal
cell lines C-2D (benign), C-2G (tumourigenic) and C-
2H (metastatic) were generated from a primary prostate
tumour in a TRAMP mouse [14] and were phenotypi-
cally defined by their ability to form tumours and
metastasis in vivo [14]. All cell lines were grown in
folate-free RPMI-1640 (Invitrogen, CA, USA) plus 10%
dialyzed fetal bovine serum (Invitrogen) supplemented
with 10
-8 dihydrotestosterone and either 100 nM FA
(Sigma-Aldrich, MO, USA; low folate) or 2 μMF A
(control) for 20 PDs. Medium was changed every 2 PD.
Anchorage-independent colony formation assay in soft
agar
Anchorage-independent colony formation assay in soft
agar was performed as previously described [37]. Briefly,
10,000 cell/well were seeded in semi-solid agar mixed
with medium in six replicates in six well plates. Agar
was covered with medium which was replaced once a
week. After 4 weeks, five fields per well were assessed
microscopically for the presence of anchorage-indepen-
dent colonies > 50 μM. The experiment was repeated
twice.
Folate-dependent growth rates
We seeded 3000 cells/well in six well plates in duplicate
with the specified amounts of FA. We carried out
counts with Trypan blue after 9 days of culture. For
each cell line we set growth in control medium (2 μM
FA) as 100% of growth and calculated the relative
growth rates in folate restricted media.
Analysis of intracellular folates by L. Casei
Intracellular quantification of folate pools was carried
out using a microbiological assay like previously
described [11,38].
HPLC analyses
HPLC analyses were carried out as previously described
[11,39,40] at the Biopolymer Facility, at Roswell Park
Cancer Institute (NY, USA).
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ROPS was carried out as previously described [16,17] in
order to measure uracil misincorporation, apyrimidinic
sites and DNA single strand breaks. We analysed at
least five independent replicates per sample (D100, DC,
G100, GC, H100, HC). Uracil misincorporation was nor-
malized, as recommended, by subtracting the back-
ground due to pre-existing single strand breaks and
apyrimidinic sites. The so-obtained data expressed as
deoxcytidine (dCTP) incorporated per microgram of
DNA per cell line grown in mild folate depletion were
expressed as a percentage of the average value obtained
for the same cells grown in control medium. Statistical
analysis of ROPS experiments was carried out on the
actual dCTP/μg values.
SKY analysis
SKY was done essentially as described [18]. Briefly,
fluorescence colour images of chromosomes developed
by Rhodamine, Texas Red, Cy5, FITC and Cy5.5 were
captured under a Nikon microscope, equipped with a
spectral cube and Interferometer module. SKY View
software (version 1.62), was used to sort numerical
changes and structural alterations of chromosomes,
including simple balanced translocations, unbalanced (or
nonreciprocal) translocations, deletions and duplications.
At least 50 metaphases were analysed per sample.
Total 5-methylcythosine analysis
We performed total 5-methylcytosine quantification by
hydrolyzing the DNA and performing a separation of
nucleotides by LC-MS as previously described [19].
RLGS
The protocol for extraction of genomic DNA from cells
was previously described by Smiraglia et al. [41,42]. The
published protocol of Dai et al. [43] was followed for
RLGS gels. RLGS spots of interest were cloned as pre-
viously described [22,41,44,45]. The resulting highly
reproducible pattern is comprised of over 1200 spots
representing as many CpGs distributed genome-wide.
Decreased spot intensity on the RLGS gel corresponds
to an increase in methylation at the corresponding CpG
[23,46].
MAQMA by Sequenom
Briefly, the DNA was bisulphite treated (EZ DNA
m e t h y l a t i o nk i t ,Z y m oR e s e a r c h ,C A ,U S A )a n dp o l y -
merase chain reaction amplified (HotStarTaq DNA
Polymerase, Qiagen, CA, USA) with bisulphite sequen-
cing primers flanking the CpGs of interest at loci identi-
fied by RLGS. MAQMA was performed using the
MassARRAY Compact system developed by the Seque-
nome Company (CA, USA) as previously described by
Ehrich et al. [47]. This system utilizes MS for the detec-
tion and quantitative analysis of DNA methylation. This
approach has been shown to a be a highly accurate and
reproducible way to quantitated DNA methylation [48].
Western Blot analyses
In order to analyse histone modifications we separated
30 μg of histone acid lysates per sample on a 15% polya-
crylamide gel, transferred the proteins onto a polyvinyli-
dene fluoride membrane a n di m m u n o b l o t t e dw i t h
antibodies specific to H3K9me1, H3K9me2, H3K9me3,
H3H36me2 and the total level of H3 as a loading con-
trol. Detection was performed with horse radish peroxi-
dase-conjugated secondary antibodies and enhanced
chemiluminescence detection on film (Pierce, IL, USA).
All antibodies were purchased from Millipore (MA,
USA). All cells were harvested at 75% confluence.
Statistical analysis
Statistical significance throughout the paper was calcu-
lated with the standard student’s t-test (unpaired, two-
tailed) unless stated otherwise.
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